KRAS and acute myeloid leukemia: Along with FLT3, other signaling pathway-affecting mutations such as Ras pathway mutations (NRAS, KRAS, HRAS, NF1, CBL and PTPN11) and KIT are some of the most common in pediatric AML, and less commonly seen in adults (6, 10, 12, 13).